Optimalization of Nephroprotection Using Agents Inhibiting Renin-Angiotensin-Aldosterone System
Condition(s):Chronic Kidney Disease; ProteinuriaLast Updated:September 12, 2007Completed
Hide Studies Not Open or Pending
Condition(s):Chronic Kidney Disease; ProteinuriaLast Updated:September 12, 2007Completed
Condition(s):Metabolic SyndromeLast Updated:January 20, 2021Completed
Condition(s):HypertensionLast Updated:November 18, 2016Completed
Condition(s):Systemic Arterial Hypertension; Hypertension Resistant to Conventional Therapy; Myocardial Infarction; StrokeLast Updated:April 22, 2013Completed
Condition(s):COVID-19Last Updated:May 5, 2020Unknown status
Condition(s):PreDiabetes; Impaired Glucose Tolerance; Obesity; Blood PressureLast Updated:August 14, 2023Active, not recruiting
Condition(s):HyperkalemiaLast Updated:April 10, 2023Recruiting
Condition(s):HyperparathyroidismLast Updated:September 21, 2017Completed
Condition(s):Obesity, AbdominalLast Updated:August 24, 2015Completed
Condition(s):Tetralogy of Fallot; Heart Defects, Congenital; Ventricular Dysfunction, RightLast Updated:December 22, 2015Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.